Communiqués

30/07 Immutep Quarterly Activities Report Q4 FY26 AQ
27/07 Immutep Announces Abstract Accepted for Presentation at the European Society for Medical Oncology Congress 2026 AQ
24/07 Immutep : Announces Abstract Accepted for Presentation at the European Society for Medical Oncology (ESMO) Congress 2026 PU
14/07 Immutep Secures Fourth United States Patent for Eftilagimod Alfa in Combination with a PD-1 Pathway Inhibitor AQ
13/07 Immutep Provides Clinical Update in 1st line NSCLC: Positive Mature Overall Survival Data from INSIGHT-003 and Update from TACTI-004 PU
30/06 Robbins LLP Urges IMMP Stockholders to Move for Lead Plaintiff Before the July 6, 2026 Deadline NE
06/06 IMMP SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Immutep (IMMP) Investors of Securities Class Action Deadline on July 6, 2026 NE
04/06 Immutep to Present Positive Interim Phase I Data for IMP761, a First-in-Class LAG-3 Agonist Antibody, at EULAR 2026 AQ
02/06 IMMP INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Immutep (IMMP) Investors of Securities Class Action Deadline on July 6, 2026 NE
01/06 SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Immutep (IMMP) Investors of Securities Class Action Deadline on July 6, 2026 NE
31/05 IMMP DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Immutep (IMMP) Investors of Securities Class Action Deadline on July 6, 2026 NE
30/05 IMMP CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Immutep (IMMP) Investors of Securities Class Action Deadline on July 6, 2026 NE
29/05 IMMP UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Immutep (IMMP) Investors of Securities Class Action Deadline on July 6, 2026 NE
28/05 Immutep : Systemic immune activation with eftilagimod alfa associated with statistically significant increased overall survival in late-stage cancer patients PU
27/05 IMMP INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Immutep (IMMP) Investors of Securities Class Action Deadline on July 6, 2026 NE
26/05 Immutep Limited Class Action Reminder - Robbins LLP Encourages IMMP Investors to Contact the Firm for Information About Their Rights BU
25/05 IMMP SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Immutep (IMMP) Investors of Securities Class Action Deadline on July 6, 2026 NE
23/05 IMMP SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Immutep (IMMP) Investors of Securities Class Action Deadline on July 6, 2026 NE
21/05 IMMP EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Immutep (IMMP) Investors of Securities Class Action Deadline on July 6, 2026 NE
20/05 IMMP SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Immutep (IMMP) Investors of Securities Class Action Deadline on July 6, 2026 NE
19/05 IMMP INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Immutep (IMMP) Investors of Securities Class Action Deadline on July 6, 2026 NE
15/05 IMMP CLASS ACTION ALERT: Johnson Fistel Encourages Immutep Limited Shareholders to Submit Their Information Before July 6, 2026 Lead Plaintiff Deadline NE
13/05 IMMP CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Immutep (IMMP) Investors of Securities Class Action Deadline on July 6, 2026 NE
12/05 IMMP INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Immutep (IMMP) Investors of Securities Class Action Deadline on July 6, 2026 NE
09/05 IMMP INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Immutep (IMMP) Investors of Securities Class Action Deadline on July 6, 2026 NE
Aucun résultat pour cette recherche